novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Nordisk is slashing GLP-1 prices by 50% in 2027 Wegovy, the weight-loss medication, gets

Both medications show favorable profiles for visual disturbances, with Tirzepatide demonstrating lower rates versus Phentermine (HR 0.45, 95% CI 0.310.68, p = 7 10 5 )

Role of intra-islet paracrine signaling in the effects of pharmaceutical targeting of GLP-1 As current therapies focusing on increasing insulin sensitivity and/or insulin secretion fail to cure diabetes, one potentially underappreciated target for diabetes treatment is the alpha-cell

Akkermansia muciniphila Akkermansia is having a moment, and the science backs the hype

Novel-Targeted Antibiotic Therapy Nammi et al

Turmeric/curcumin may have mild glucose-lowering effects and can influence platelet function at higher intakes, particularly when combined with other agents that affect coagulation

Use the Peptide Stack Calculator to map the protocol